Autek China Inc.

Equities

300595

CNE100002MR0

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
18.83 ^CNY	-1.62%		+4.26%	-16.61%

Apr. 29	Nomura Adjusts Autek China’s Price Target to 19.96 Yuan From 22.16 Yuan, Keeps at Neutral	MT
Apr. 26	Autek China Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Autek China Inc. agreed to acquire an additional 38.99% stake in Xuancheng Mengdaiwei Medical Devices Co., Ltd. from Huangyan Yulu and Hu Chenying for CNY 21.15 million

June 18, 2023

Autek China Inc. (SZSE:300595) agreed to acquire an additional 38.99% stake in Xuancheng Mengdaiwei Medical Devices Co., Ltd. from Huangyan Yulu and Hu Chenying for CNY 21.15 million on June 16, 2023.

Latest news about Autek China Inc.

Nomura Adjusts Autek China’s Price Target to 19.96 Yuan From 22.16 Yuan, Keeps at Neutral	Apr. 29	MT
Autek China Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Autek China Inc. Announces Profit Distribution Proposal for 2023	Apr. 01	CI
Nomura Adjusts Ovctek China’s Price Target to 22.16 Yuan From 25.69 Yuan, Keeps at Neutral	Mar. 13	MT
Autek China Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23	CI
Nomura Adjusts Ovctek China's Price Target to 30.19 Yuan From 33.83 Yuan, Keeps at Neutral	23-08-14	MT
Autek China Logs Double-Digit Earnings Growth in H1	23-08-11	MT
Autek China Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-10	CI
Autek China Elects Founder as Chairman, General Manager	23-06-19	MT
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Shenzhen Mingmou Ruishi Eye Clinic from Zhao Xiaoting, and Li Xianting for CNY 20.7 million.	23-06-18	CI
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Kunming Shikang Eye Clinic Co., Ltd. from Yunnan Shilikang Enterprise Management Partnership Enterprise (Limited Partnership), Zhang Mingjing, and Ouyang Zhonghua for CNY 58.2 million.	23-06-18	CI
Autek China Inc. agreed to acquire an additional 30% stake in Xuancheng Autek Baixiu Medical Devices Co., Ltd. from Huang Guanglu and Liu Jihua for CNY 21.93 million	23-06-18	CI
Autek China Inc. agreed to acquire an additional 38.99% stake in Xuancheng Mengdaiwei Medical Devices Co., Ltd. from Huangyan Yulu and Hu Chenying for CNY 21.15 million	23-06-18	CI
Autek China Inc. entered into an agreement to acquire additional 39% stake in Quanzhou Autek Optical Technology Co., Ltd. from Zhuang Chaoyang, and Zheng Jing for approximately CNY 30 million.	23-06-18	CI
Autek Investment Co., Ltd. entered into an agreement to acquire 39% stake in Suzhou Kangshi Health Eye Information Consulting Co., Ltd. from Yuan Lili and Sun Weiling for CNY 107 million.	23-06-18	CI
Autek China Inc. agreed to acquire a 39% stake in Xiantao Jiashi Eye Clinic Co., Ltd. from Wang Tiehan for CNY 17.41 million	23-06-18	CI
Autek China Inc. signed the share transfer agreement to acquire an additional 39% stake in Bengbu Autek Optical Equipment Technology Co., Ltd. from Shi Jing for CNY 45 million.	23-06-18	CI
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Xuancheng Dental Hospital Co., Ltd. from Huang Chaohui, He Xiaoqing for CNY 16.3 million.	23-06-18	CI
Autek China Inc. (SZSE : 300595) signed the share transfer agreement to acquire additional 39% stake in Fuzhou Autek Medical Devices Co., Ltd. from Ye Xiaodan, Liao Lianming and Luo Dongming for CNY 20.4 million.	23-06-18	CI
Autek China Inc. (SZSE : 300595) signed the share transfer agreement to acquire additional 39% stake in Fuzhou Autek Medical Devices Co., Ltd. from Ye Xiaodan, Liao Lianming and Luo Dongming for approximately CNY 120 million.	23-06-18	CI
Autek China Inc. (SZSE : 300595) signed the share transfer agreement to acquire additional 39% stake in Jingjiang Autek Jingcheng Eye Health Service Co., Ltd. from Hou Aihua and Lu Hanxing for CNY 21.5 million.	23-06-18	CI
Autek China Inc. Announces Final Dividend on A Shares for the Year 2022, Payable on May 16, 2023	23-05-09	CI
Autek China Inc. Approves Election of Xu Qiang Independent Director	23-04-27	CI
Autek China Inc. Approves 2022 Profit Distribution Plan	23-04-27	CI
Nomura Adjusts Autek China’s Price Target to 33.83 Yuan From 37.60 Yuan, Keeps at Neutral	23-04-25	MT

Chart Autek China Inc.

Duration

Period

More charts

Company Profile

Autek China Inc is a China-based company principally engaged in the research and development, production and sales of eye-sight products and the provision of eye-sight services. The Company's main business is non-surgical vision correction. The Company's main products include orthokeratology, general contact lens and care products. Its core product is Dream David orthokeratology. In addition, The Company is also engaged in general glass frame sales business. The Company mainly operates its business in the domestic market.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Autek China Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

18.83 CNY

Average target price

24.85 CNY

Spread / Average Target

+31.99%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
AUTEK CHINA INC.	-16.61%	2.33B
ESSILORLUXOTTICA	+11.23%	98.38B
ALCON INC.	+9.93%	39.34B
THE COOPER COMPANIES, INC.	-4.20%	18.02B
WARBY PARKER INC.	-10.04%	1.51B
PEGAVISION CORPORATION	+26.36%	1.21B
MINGYUE OPTICAL LENS CO.,LTD.	-34.97%	755M
MENICON CO., LTD.	-36.42%	744M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-8.48%	665M
VIZIONFOCUS INC.	+26.67%	509M

Glasses, Spectacles & Contact Lenses